Meghan is on the investment team at Breakthrough Energy Ventures (BEV), a venture capital firm seeking to finance and scale companies that will eliminate greenhouse gas emissions throughout the global economy. Prior to joining BEV, Meghan worked at the Harvard University Office of Technology Development, commercializing innovations from Harvard research labs through intellectual property protection, translational funding, and startup creation. Meghan started her career in research and development at Arsenal Medical, an early-stage company developing therapeutic biomaterials. She earned her Ph.D. in Biomedical Engineering from Tufts University where she was an NSF Graduate Research Fellow, and her B.S. in Chemical Engineering from Northeastern University.